Petmed Express Inc PETS
We take great care to ensure that the data presented and summarized in this overview for PETMED EXPRESS INC is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding PETS
View all-
Jim Simons Renaissance Technologies LLC | New York, Ny1.28MShares$4.31 Million0.01% of portfolio
-
Hotchkis & Wiley Capital Management LLC Los Angeles, CA974KShares$3.29 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA964KShares$3.26 Million0.0% of portfolio
-
Black Rock Inc. New York, NY556KShares$1.88 Million0.0% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA538KShares$1.82 Million0.01% of portfolio
-
Arrowstreet Capital, Limited Partnership Boston, MA513KShares$1.74 Million0.0% of portfolio
-
Oaktop Capital Management Ii, L.P. Chatham, NJ436KShares$1.47 Million0.35% of portfolio
-
Metavasi Capital LP Larchmont, NY340KShares$1.15 Million0.64% of portfolio
-
Geode Capital Management, LLC Boston, MA225KShares$759,7830.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX217KShares$732,8240.0% of portfolio
Latest Institutional Activity in PETS
Top Purchases
Top Sells
About PETS
PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes. The company also sells food, beds, crates, stairs, and other pet supplies. It sells its products through its Internet website; mobile app; telephone contact center; and direct mail/print, which includes brochures and postcards, as well as television advertising under the 1-800-PetMeds and PetMeds brands. PetMed Express, Inc. was incorporated in 1996 and is headquartered in Delray Beach, Florida.
Insider Transactions at PETS
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|
Apr 09
2025
|
Peter Batushansky Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,527
+50.0%
|
-
|
|
Mar 18
2025
|
Nina Capital Holdings Inc. > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
100,000
+3.85%
|
$400,000
$4.08 P/Share
|
|
Mar 10
2025
|
Nina Capital Holdings Inc. > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
100,000
+4.0%
|
$400,000
$4.11 P/Share
|
|
Mar 03
2025
|
Nina Capital Holdings Inc. > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
50,000
+2.13%
|
$200,000
$4.33 P/Share
|
|
Feb 03
2025
|
Nina Capital Holdings Inc. > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
25,000
+1.1%
|
$100,000
$4.82 P/Share
|
|
Jan 27
2025
|
Nina Capital Holdings Inc. > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
25,000
+1.11%
|
$100,000
$4.63 P/Share
|
|
Jan 24
2025
|
Nina Capital Holdings Inc. > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
25,000
+1.12%
|
$100,000
$4.95 P/Share
|
|
Jan 15
2025
|
Sandra Yvette Campos CEO & President |
BUY
Grant, award, or other acquisition
|
Direct |
146,772
+18.68%
|
-
|
|
Jan 15
2025
|
Jacqueline Paula Smith |
BUY
Grant, award, or other acquisition
|
Direct |
8,000
+22.16%
|
-
|
|
Jan 07
2025
|
Nina Capital Holdings Inc. > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
25,000
+1.14%
|
$100,000
$4.97 P/Share
|
|
Dec 16
2024
|
Nina Capital Holdings Inc. > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
32,000
+1.47%
|
$160,000
$5.66 P/Share
|
|
Dec 06
2024
|
Nina Capital Holdings Inc. > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
40,000
+1.85%
|
$200,000
$5.55 P/Share
|
|
Dec 05
2024
|
Leslie C.G. Campbell Director |
BUY
Open market or private purchase
|
Indirect |
15,000
+16.98%
|
$75,000
$5.44 P/Share
|
|
Dec 05
2024
|
Leslie C.G. Campbell Director |
BUY
Open market or private purchase
|
Direct |
15,000
+5.9%
|
$75,000
$5.42 P/Share
|
|
Dec 04
2024
|
Leslie C.G. Campbell Director |
BUY
Open market or private purchase
|
Indirect |
15,000
+37.5%
|
$75,000
$5.41 P/Share
|
|
Dec 04
2024
|
Leslie C.G. Campbell Director |
BUY
Open market or private purchase
|
Direct |
15,000
+7.17%
|
$75,000
$5.38 P/Share
|
|
Sep 27
2024
|
Robyn M. D'Elia Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
250,000
+50.0%
|
-
|
|
Sep 09
2024
|
Nina Capital Holdings Inc. > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
12,500
+0.6%
|
$37,500
$3.34 P/Share
|
|
Aug 15
2024
|
Jacqueline Paula Smith |
SELL
Open market or private sale
|
Direct |
601
-2.9%
|
$1,803
$3.19 P/Share
|
|
Aug 08
2024
|
Gian Fulgoni Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,500
+5.68%
|
-
|
Last 12 Months Summary
| Grant, award, or other acquisition | 522K shares |
|---|---|
| Open market or private purchase | 495K shares |
| Sale (or disposition) back to the issuer | 41.3K shares |
|---|---|
| Open market or private sale | 601 shares |